Genesis IT AB (publ)

NGM:GENE Voorraadrapport

Marktkapitalisatie: SEK 262.9m

Genesis IT Toekomstige groei

Future criteriumcontroles 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Genesis IT.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Software winstgroei35.0%
Inkomstengroein/a
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

None

Laatst bijgewerktn/a

Recente toekomstige groei-updates

Geen updates

Recent updates

The Returns On Capital At Genesis IT (NGM:GENE) Don't Inspire Confidence

Nov 23
The Returns On Capital At Genesis IT (NGM:GENE) Don't Inspire Confidence

Genesis IT (NGM:GENE) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Sep 06
Genesis IT (NGM:GENE) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Some Investors May Be Worried About Genesis IT's (NGM:GENE) Returns On Capital

Aug 28
Some Investors May Be Worried About Genesis IT's (NGM:GENE) Returns On Capital

A Look At The Fair Value Of Genesis IT AB (publ) (NGM:GENE)

May 30
A Look At The Fair Value Of Genesis IT AB (publ) (NGM:GENE)

Has Genesis IT (NGM:GENE) Got What It Takes To Become A Multi-Bagger?

Mar 15
Has Genesis IT (NGM:GENE) Got What It Takes To Become A Multi-Bagger?

Genesis IT AB (publ)'s (NGM:GENE) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?

Feb 17
Genesis IT AB (publ)'s (NGM:GENE) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?

Is Genesis IT AB (publ)'s(NGM:GENE) Recent Stock Performance Tethered To Its Strong Fundamentals?

Jan 06
Is Genesis IT AB (publ)'s(NGM:GENE) Recent Stock Performance Tethered To Its Strong Fundamentals?

The Trends At Genesis IT (NGM:GENE) That You Should Know About

Dec 10
The Trends At Genesis IT (NGM:GENE) That You Should Know About

How Does Genesis IT AB (publ) (NGM:GENE) Stand Up To These Simple Dividend Safety Checks?

Nov 19
How Does Genesis IT AB (publ) (NGM:GENE) Stand Up To These Simple Dividend Safety Checks?

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Genesis IT onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

NGM:GENE - Toekomstschattingen van analisten en financiële gegevens uit het verleden (SEK Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
6/30/202376101116N/A
3/31/20237411816N/A
12/31/20227311616N/A
9/30/20227312520N/A
6/30/20227212116N/A
3/31/20227011116N/A
12/31/20216911114N/A
9/30/2021679211N/A
6/30/20216791218N/A
3/31/202173141319N/A
12/31/202080182026N/A
9/30/202084192127N/A
6/30/202089211723N/A
3/31/202089191926N/A
12/31/201988181319N/A
9/30/201987181421N/A
6/30/201985181522N/A
3/31/201986192227N/A
12/31/201888202428N/A
9/30/2018116262932N/A
6/30/201895202224N/A
3/31/201896211864N/A
12/31/201796211360N/A
9/30/20177116752N/A
6/30/201793242168N/A
3/31/20179023N/A26N/A
12/31/20168218N/A24N/A
9/30/20167713N/A21N/A
6/30/2016719N/A12N/A
3/31/2016647N/A12N/A
12/31/2015607N/A14N/A
9/30/20154510N/A19N/A
6/30/2015488N/A20N/A
3/31/2015445N/A14N/A
12/31/2014435N/A6N/A
8/31/2014505N/A5N/A
5/31/2014446N/A4N/A
2/28/20144811N/A10N/A
11/30/20134511N/A19N/A
8/31/2013368N/A9N/A
5/31/2013356N/A9N/A
2/28/2013261N/A4N/A
11/30/2012241N/A3N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Insufficient data to determine if GENE's forecast earnings growth is above the savings rate (0.7%).

Winst versus markt: Insufficient data to determine if GENE's earnings are forecast to grow faster than the Swedish market

Hoge groeiwinsten: Insufficient data to determine if GENE's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: Insufficient data to determine if GENE's revenue is forecast to grow faster than the Swedish market.

Hoge groei-inkomsten: Insufficient data to determine if GENE's revenue is forecast to grow faster than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if GENE's Return on Equity is forecast to be high in 3 years time

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y